✦ LIBER ✦

Enhancing the validity and utility of randomized clinical trials in addictions treatment research: III. Data processing and statistical analysis

✍ Scribed by Frances K. Del Boca; Jack Darkes

Book ID: 108598010
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 97 KB
Volume: 102
Category: Article
ISSN: 0965-2140
DOI: 10.1111/j.1360-0443.2007.01864.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enhancing the validity and utility of ra

Enhancing the validity and utility of randomized clinical trials in addictions treatment research: I. Treatment implementation and research design

✍ Frances K. Del Boca; Jack Darkes 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Enhancing the validity and utility of ra

Enhancing the validity and utility of randomized clinical trials in addictions treatment research: II. Participant samples and assessment

✍ Frances K. Del Boca; Jack Darkes 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

Efficacy and safety of the six-dose regi

Efficacy and safety of the six-dose regimen of artemether–lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in adolescents and adults: A pooled analysis of individual patient data from randomized clinical trials

✍ Edgar A. Mueller; Michele van Vugt; Wilhelm Kirch; Kim Andriano; Philip Hunt; Pa 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Efficacy of bupropion and the selective

Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of anxiety symptoms in major depressive disorder: A meta-analysis of individual patient data from 10 double-blind, randomized clinical trials

✍ George I. Papakostas; Madhukar H. Trivedi; Jonathan E. Alpert; Cheryl A. Seifert 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Letter to the Editor: Survival analysis

Letter to the Editor: Survival analysis of randomized clinical trials adjusted for patients who switch treatments by M. G. Law and J. M. Kaldor, Statistics in Medicine, 15, 2069–2076 (1996)

✍ I. R. White 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

Law and Kaldor address the important question of clinical trials with survival outcomes in which subjects may change in a non-randomized manner from one randomized treatment to the other during the course of follow-up. These changes make the treatment experience of the two randomized groups more sim

The incidence of arthropathy adverse eve

The incidence of arthropathy adverse events in efalizumab-treated patients is low and similar to placebo and does not increase with long-term treatment: pooled analysis of data from Phase III clinical trials of efalizumab

✍ Carlo Pincelli; Eric Henninger; Florence Casset-Semanaz 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 475 KB